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Abstract	
In	the	Odense	child	cohort,	serum	concentrations	of	perfluorooctanesulfonic	acid	(PFOS),	perfluorooctanoic	
acid	(PFOA),	perfluorohexane	sulfonic	acid	(PFHxS),	perfluorononanoic	acid	(PFNA),	and	perfluorodecanoic	acid	
(PFDA)	were	measured	in	638	pregnant	women.	Birth	weight,	head	and	abdominal	circumferences	and	
gestational	age	were	determined.	Anogenital	distance	(AGD),	the	distance	from	the	anus	to	the	genital	organs,	
and	penile	width	were	measured	3	months	after	expected	date	of	birth	in	511	children.	PFOS,	PFHxS,	PFNA	and	
PFDA	were	associated	with	a	decreased	AGD	in	girls	(p-trend	<	0.05)	after	adjusting	for	age	and	weight-for-age	
standard	deviation	score.	PFOS	in	the	highest	quartile	was	associated	with	a	2.8	mm	(95%	confidence	intervals	
-4.5;	-1.1)	reduction	in	AGD	in	girls.	No	such	tendencies	were	seen	in	boys.	However,	a	tendency	toward	
increased	birth	weight	in	girls	and	reduced	birth	weight	in	boys	suggests	that	sex-dimorphic	effects	may	occur	
from	endocrine	disrupting	effects	of	these	substances.	
	
	 	
1.	Introduction	
Perfluoroalkyl	substances	(PFASs)	are	synthetic	chemicals	produced	in	high	quantities	(Lindstrom,	Strynar,	&	
Libelo,	2011).	Their	unique	properties	of	high	stability	and	low	surface	tension	make	them	grease	and	water	
repellant	and	therefore	suitable	for	use	in	a	wide	range	of	consumer	products	like	food	packaging,	textiles,	
outdoor	clothes,	footwear	and	carpets;	they	are	also	used	in	paints,	lubricants,	waxes	and	in	firefighting	foams	
(Lindstrom	et	al.,	2011;	OECD,	2013).	Perfluorooctanoic	acid	(PFOA)	and	perfluorooctane	sulfonic	acid	(PFOS)	
have	been	most	widely	used;	they	are	persistent	in	the	environment	and	bio-accumulate	(Lindstrom	et	al.,	
2011).	They	can	be	detected	in	human	serum	in	Western	populations,	and	they	cross	the	placenta	(Lindstrom	
et	al.,	2011;	Needham	et	al.,	2011).	PFASs	have	a	long	elimination	half-life		-PFOS,	5.4	years	and	PFOA,	3.8	years	
(G.	W.	Olsen	et	al.,	2007).	In	recent	years,	the	use	and	production	of	PFOA	and	PFOS	have	been	phased	out	due	
to	the	growing	knowledge	about	their	adverse	health	effects	(Lindstrom	et	al.,	2011).		However,	they	have	
been	replaced	with	the	shorter	and	longer	chained	PFASs	(e.g	perfluorohexane	sulfonic	acid	(PFHxS),	
perfluorononanoic	acid	(PFNA),	and	perfluorodecanoic	acid	(PFDA))	(Glynn	et	al.,	2012)	whose	adverse	effects	
have	been	studied	less	extensively.	
Among	other	important	adverse	effects,	PFASs	may	have	endocrine	disrupting	properties	(Lau	et	al.,	
2007).	PFASs	influence	the	expression	of	estrogen-responsive	genes	in	animal	studies	(Benninghoff	et	al.,	
2011),	and	PFAS-induced	changes	in	sex	hormone	biosynthesis	have	been	reported	in	vitro	(Du	et	al.,	2013).	
PFASs	have	been	shown	to	interfere	with	the	estrogen	receptor	in	human	in	vitro	studies	(Kjeldsen	&	Bonefeld-
Jorgensen,	2013).	PFAS	exposure	has	been	associated	with	fetal	growth,	and	a	recent	review	found	that	
maternal	exposure	to	PFOA	and	PFOS	was	associated	with	low	birth	weight,	although	the	results	were	
equivocal,	perhaps	due	to	differences	in	exposure	and	sex-dimorphic	effects	(Bach	et	al.,	2014).		
Anogenital	distance	(AGD;	distance	from	anus	to	genitals)	is	routinely	used	in	animal	toxicology	studies	
and	is	sensitive	to	anti-androgenic	exposure.	In	rodents	AGD	has	been	shown	to	reflect	the	amount	of	
androgen	to	which	a	male	fetus	is	exposed	in	early	development;	males	have	longer	AGD	than	females,	and	
higher	in	utero	androgen	exposure	results	in	longer	AGD	(Welsh	et	al.,	2008).	Numerous	studies	have	shown	
that	prenatal	phthalate	exposure	shortens	male	AGD	in	rodents	and	humans	(Foster,	2006;	T.	K.	Jensen	et	al.,	
2016).	High	prenatal	exposure	to	testosterone	has	also	been	associated	with	longer	AGD	in	female	rodent	
offspring,	suggesting	masculinization	effects,	and	the	changes	were	found	to	be	indicators	of	permanent	
alteration	in	AGD	in	the	adult	female	rodent	(Hotchkiss	et	al.	2007).	To	our	knowledge	no	human	investigations	
have	studied	the	effects	of	maternal	PFAS	exposure	on	AGD	in	the	offspring,	but	PFASs	exposure	in	wild	male	
mink	has	been	associated	with	shorter	AGD	(Persson	&	Magnusson,	2014).		
We	therefore	investigated	the	association	between	maternal	PFAS	exposure,	including	the	less	studied	
perfluorononanoic	acid	(PFNA),	perfluorodecanoic	acid	(PFDA)	and	perfluorohexane	sulfonic	acid	(PFHxS),	and	
birth	outcomes	(birth	weight,	head	and	abdominal	circumference	and	gestational	length)	and	AGD	at	three	
months	of	age.	
	
2.	Materials	and	Methods	
2.1	Study	population	
This	study	is	based	on	data	from	the	ongoing	Odense	Child	Cohort	(OCC).		All	women	residing	in	the	
Municipality	of	Odense	in	the	Region	of	Southern	Denmark,	who	were	pregnant	between	January	2010	and	
December	2012,	were	invited	to	participate.	The	pregnant	women	were	recruited	at	a	voluntary	information	
meeting	introducing	the	ultrasound	examinations	at	Odense	University	Hospital	(OUH)	or	at	their	first	
antenatal	visit	at	gestational	week	8	to	16.	Serum	samples	were	collected	at	recruitment	and	stored	in	freezers	
at	the	Odense	Patient	data	Explorative	Network	(OPEN).	A	total	of	6,707	pregnant	women	were	eligible,	4,017	
were	approached,	and	2,874	(42.9%)	were	successfully	enrolled	in	the	cohort	with	an	informed	consent	form.	
The	pregnant	women	filled	in	a	questionnaire	about	general	health	and	lifestyle.	Participants	were	better	
educated,	smoked	less	and	were	more	often	of	Danish	origin	than	non-participants	(Kyhl	et	al.,	2015).	As	of	
November	2014,	2,448	singleton	children	were	active	members	of	the	cohort.		
	2.2	Birth	outcome,	AGD	and	covariates	
We	obtained	information	from	birth	records	about	parity,	maternal	smoking,	maternal	pre-pregnancy	BMI,	
gestational	age	(days)	at	birth	and	birth	measures	such	as	birth	weight	(grams),	head	circumference	(cm),	and	
abdominal	circumference	(cm).	Midwives	assessed	birth	size	right	after	parturition.	Maternal	ethnicity	and	
education	were	obtained	from	a	questionnaire	completed	in	early	pregnancy.		
Three	months	after	expected	date	of	birth	(median	age	3.5	months,	range	2.1	to	6.8	months)	the	
children	were	invited	to	a	clinical	examination	including	measurements	of	length,	weight	and	AGD.	In	boys,	a	
short	AGD	was	measured	with	a	Vernier	caliper	from	the	center	of	the	anus	to	the	posterior	base	of	the	
scrotum	(AGDas)	and	a	long	AGD	was	measured	from	the	center	of	the	anus	to	the	cephalad	insertion	of	the	
penis	(AGDap).	Penile	width	was	also	measured.	Correspondingly,	in	girls	a	short	AGD	was	measured	from	the	
center	of	the	anus	to	the	posterior	fourchette	(AGDaf)	and	a	long	AGD	from	the	center	of	the	anus	to	the	top	of	
the	clitoris	(AGDac).	The	genital	measures	were	performed	blindly	and	repeated	three	times	in	each	child,	and	
an	arithmetic	mean	was	calculated.	All	technicians	attended	training	sessions	and	supervision.	AGD	
measurements	for	the	first	46	girls	were	excluded	due	to	low	accuracy.	The	coefficient	of	variation	(CV)	for	
AGDs	was	below	10%	(3%	on	average	for	AGDas,	2%	for	AGDap,	4%	for	AGDaf	and	3%	for	AGDac)	for	all	the	
triplicate	AGD	measurements,	except	for	AGDaf,	in	which	two	girls	had	CVs	of	0.10	and	0.14,	respectively.		
	
2.3	PFAS	measurements		
PFASs	were	measured	in	serum	samples	obtained	at	gestational	week	5-12	(median	10	weeks)	from	a	subset	of	
649	pregnant	women.	The	first	200	samples	were	selected	at	random	among	women	recruited	in	2010,	
whereas	an	additional	449	were	selected	in	2011-2012	among	those	women	who	had	available	information	
from	questionnaires,	birth	records	and	a	clinical	3-month	examination	of	the	child.	Three	mothers	from	2010	
did	not	satisfy	the	latter	criteria,	and	a	total	638	children	were	therefore	eligible	for	analyses	of	associations	
between	birth	outcomes	and	PFASs.	The	analysis	of	serum	PFAS	concentrations	was	performed	by	on-line	solid	
phase	extraction	followed	by	liquid	chromatography	and	triple	quadropole	mass	spectrometry	(LC-MS/MS).	
The	quantified	PFASs	are	comprised	of	perfluorooctanesulfonic	acid	(PFOS),	perfluorooctanoic	acid	(PFOA),	
perfluorohexane	sulfonic	acid	(PFHxS),	perfluorononanoic	acid	(PFNA),	and	perfluorodecanoic	acid	(PFDA)	
(Haug,	Thomsen,	&	Becher,	2009).	The	Limit	of	Quantification	(LOQ)	was	0.03	ng/mL	for	all	the	reported	
compounds.	Non-detectable	concentrations	were	found	only	in	a	small	number	of	samples	and	were	replaced	
with	half	of	the	limit	of	quantification	LOQ	(i.e.	0.015	ng/mL)	(United	States	Environmental	Protection	Agency,	
2000).	Results	from	the	first	200	samples	and	further	descriptions	of	PFAS	measurements	have	been	reported	
elsewhere	(Vorkamp	et	al.,	2014).	
	
2.4.	Ethics	
The	study	complied	with	the	Declaration	of	Helsinki	and	was	approved	by	the	health	research	ethics	committee	
system	in	Denmark	(S-20090130)	and	the	Danish	Data	Protection	Agency	(j.no.	2008-58-0035).	
	
2.5	Statistics	
PFASs	distributions	were	skewed	and	were	therefore	divided	into	quartiles,	but	also	entered	as	continuous	
variables	after	transformation	by	the	natural	logarithm	to	approach	normality.	Differences	in	serum-PFAS	
concentrations	according	to	characteristics	of	the	pregnant	women	were	first	tested	by	Kruskal	Wallis	test.		
Multiple	linear	regression	analysis	was	used	to	analyze	the	associations	between	maternal	PFASs	
exposure	and	birth	outcomes	(birth	weight,	head	and	abdominal	circumference	and	gestational	age),	AGD	and	
penile	width	at	3-months	of	age	adjusted	for	potential	confounders.	We	tested	for	linear	trends	across	PFASs	
quartiles	in	regression	models	by	means	of	ordinal	PFASs	quartiles	using	integer	values	from	1	to	4.	
Confounders	included	in	multivariable	models	were	factors	known	a	priori	to	be	important	predictors	of	birth	
outcomes	or	AGD.	The	AGD	measurements,	penile	width	and	birth	outcomes	were	left	untransformed	due	to	
acceptable	normal	distributions	of	the	residuals.	The	analyses	of	birth	outcomes	were	adjusted	for	gestational	
age	(days),	parity	(primiparous/multiparous),	maternal	smoking	during	pregnancy	(yes/no),	pre-pregnancy	BMI	
(<20,	20-25,	25+	kg/m2),	maternal	ethnicity	(mother	or	maternal	parents	born	in	Western	countries	(yes/no),	
maternal	education	separated	into	primary	(minimum	9th	grade),	secondary	(minimum	high	school	or	
equivalent),	and	tertiary	(minimum	bachelor	degree	or	equivalent).	Maternal	education	and	ethnicity	were	
omitted	from	the	final	model,	as	they	were	not	associated	with	any	birth	outcome.	All	analyses	were	tested	for	
sex-dimorphic	effects	and	stratified	on	child	sex.		
The	multiple	linear	regression	analyses	of	the	associations	between	maternal	PFASs	exposure	and	AGD	
in	the	offspring	were	restricted	to	women	of	Western	origin	since	AGD	differed	between	children	of	Western	
and	non-Western	origin.	Since	AGD	measurements	vary	with	age	and	weight	of	the	child,	we	constructed	a	
measure	of	“post-conceptional	age”	at	the	time	of	AGD	measurement	as	the	sum	of	gestational	age	at	birth	(in	
days)	and	the	age	of	the	child	at	the	AGD	measurements	(in	days).	Z-scores	for	the	weight	of	child	at	the	time	
of	AGD	measurement	were	calculated	separately	for	boys	and	girls	using	all	2,041	singleton	children	who	
underwent	the	3-month	examination	in	Odense	Child	Cohort	as	reference.	Analyses	of	associations	between	
PFASs	and	AGD	were	adjusted	for	post-conceptional	age,	z-score	for	weight	at	3	months,	parity,	maternal	
smoking,	and	pre-pregnancy	BMI.		
Residual	plots	were	used	to	examine	the	model	assumption	of	homogeneity	of	variances.	Associations	
were	considered	statistically	significant	at	the	p	<	0.05	level	and	presented	with	95%	confidence	intervals	(CIs).	
All	data	analyses	were	performed	using	STATA.	
	
3.	Results	
The	mean	age	of	the	women	at	parturition	was	30.7	years,	58%	of	the	women	were	nulliparous,	3%	were	of	
non-Western	origin	and	3.2	%	smoked	during	pregnancy.	Mean	birth	weight	was	3,474g	for	girls	and	3,600g	for	
boys.	Means	of	head	circumference	were	34.9	and	35.3	cm,	and	mean	abdominal	circumferences	were	33.3	
and	33.6	cm	for	girls	and	boys,	respectively.	Mean	gestational	length	was	279.6	days	for	both	boys	and	girls.	
Birth	weight,	abdominal	and	head	circumference,	sex,	parity	and	age	did	not	differ	between	women	who	had	
their	serum	PFASs	measured	(N=638)	and	women	who	did	not	(N=1,787).	Fewer	women	with	PFASs	
measurements	smoked	compared	to	those	without	PFASs	measurements	(3.2%	vs.	5.3%	p=0.03).		
PFOS,	PFOA,	PFNA,	PFDA	were	found	in	quantifiable	concentrations	in	serum	of	all	649	women,	while	
PFHxS	was	found	in	99%	of	the	women	(Table	1).	The	200	women	who	gave	birth	in	2010	had	higher	
concentrations	of	PFOA	(p<0.01),	PFOS	(p=0.08)	and	PFNA	(p=0.17),	but	significantly	lower	concentrations	of	
PFHxS	(p<0.01)	and	PFDA	(p<0.01)	compared	to	the	449	women	who	gave	birth	in	2011-2012.	Parity	and	age	
were	negatively	associated	with	PFASs.	Women	with	high	PFOA	exposure	were	more	often	smokers	and	gave	
birth	to	children	with	low	birth	weight	(Table	1).		
Effects	of	PFASs	exposure	on	birth	weight	were	modified	by	sex	(p-value	for	interaction	between	sex	
and	PFASs	on	birth	weight;	PFOA	p=0.26,	PFOS	p=0.06,	PFHxS	p=0.70,	PFNA	p=0.04,	PFDA	p=0.04),	and	
therefore	all	analyses	were	stratified	by	sex.	No	significant	associations	between	maternal	PFOA,	PFOS,	PFHxS	
and	PFNAs	exposure	and	birth	weight	or	gestational	length	were	found	for	boys	or	girls	(Table	S1).	There	was	a	
tendency	of	maternal	PFOS,	PFNA	and	PFDA	to	be	associated	with	reduced	birth	weight	in	boys	and	increased	
birth	weight	in	girls	(Figure	S1)	although	this	was	not	statistically	significant.	When	PFASs	exposures	were	
entered	as	continuous	variables	no	significant	associations	to	birth	weight,	head	and	abdominal	circumference	
were	found	(Table	s1).		
A	total	of	316	boys	and	231	girls	of	mothers	with	available	PFASs	exposure	had	AGD	measured.	No	
consistent	patterns	were	found	between	maternal	PFASs	exposure	and	AGD	and	penile	width	among	boys	
(Table	2,	Figure	1a).	Among	girls	maternal	exposure	to	all	PFASs	in	the	higher	quartiles	was	associated	with	a	
decreased	AGDac,	p-trend	for	continuous	PFAS	exposure<0.05	for	PFOS,	PFHxS,	PFNA	and	PFDA.	Maternal	PFOS	
exposure	in	the	highest	quartile	was	associated	with	2.8	mm	(-4.5;	-1.1)	reduction	in	AGDac	(Table	2,	Figure	1b).		
	
4.	Discussion	
In	this	prospective	cohort	study	we	found	an	association	between	maternal	exposure	to	PFASs	and	reduced	
AGDac	in	girls,	but	AGD	among	boys	was	not	affected.	We	did	not	find	an	association	between	maternal	PFASs	
exposure	and	birth	outcomes,	however,	a	tendency	towards	lower	birth	weight	among	boys	and	higher	birth	
weight	among	girls	with	high	prenatal	PFOS,	PFNA	and	PFDA	exposures	was	found.	Thus,	PFASs	may	have	
endocrine	disrupting	abilities	as	suggested	by	changes	in	AGD	and	a	sex-dimorphic	effect	on	birth	weight.		
Findings	from	other	human	studies	of	the	adverse	effects	of	prenatal	PFASs	exposure	on	birth	
outcomes	(Geary	W.	Olsen,	Butenhoff,	&	Zobel,	2009)	have	been	somewhat	inconsistent.	However,	a	recent	
review	concluded	that	PFOA	exposure	was	associated	with	a	lower	birth	weight	in	eight	published	studies	
(Bach	et	al.,	2014).	Six	out	of	eight	published	studies	found	that	higher	PFOS	exposure	was	associated	with	
lower	birth	weight.	However,	the	associations	were	only	statistically	significant	in	a	few	studies	(Bach	et	al.,	
2014).	We	found	no	association	between	PFOA	and	PFOS	exposure	and	birth	weight.	However,	our	exposure	
levels	were	lower	than	in	previous	studies.	The	Danish	National	Birth	Cohort,	which	included	1,400	pregnant	
women	recruited	from	1996-2002,	reported	average	serum	concentrations	of	PFOS	and	PFOA	3-	to	4-fold	
higher	than	our	study	(PFOS	mean,	35.5	ng/mL;	PFOA	mean,	5.6	ng/mL)	(Fei,	McLaughlin,	Tarone,	&	Olsen,	
2007).	They	found	a	statistically	significant	association	between	prenatal	PFOA	exposure	and	low	birth	weight,	
but	no	effect	of	PFOS	exposure	(Fei	et	al.,	2007).	An	American	study	conducted	in	areas	with	PFOA	
contaminated	drinking	water	found	no	significant	association	between	prenatal	PFOA	exposure	and	pregnancy	
outcome	(preterm	birth,	gestational	age,	birth	weight,	still	birth)	even	though	the	women	had	high	PFOA	
exposure	levels	(PFOA	mean,	31.0	ng/mL)(Darrow,	Stein,	&	Steenland,	2013;	Savitz	et	al.,	2012).	Similarly,	two	
Canadian	studies	did	not	find	any	associations	between	PFOA,	PFOS,	PFHxS	and	PFNA	exposure	and	birth	
weight	(Hamm,	Cherry,	Chan,	Martin,	&	Burstyn,	2010;	Monroy	et	al.,	2008).	Although	a	cohort	study	of	429	
pregnant	women	from	Taiwan	found	a	decreased	birth	weight	and	head	circumference	at	increasing	PFOS	
exposure,	no	associations	were	observed	for	PFOA	and	PFNA	(Chen	et	al.,	2012).	To	our	knowledge,	no	other	
human	studies	have	examined	the	associations	between	prenatal	PFNA	and	PFDA	exposures	and	birth	
outcomes.	In	addition,	most	previous	studies	did	not	stratify	their	findings	by	sex,	as	suggested	by	Bach	et	al.,	
thus	possibly	overlooking	potential	sex-dimorphic	effects,	as	we	found	a	tendency	for	girls	to	have	increased	
birth	weight	and	boys	to	have	a	reduced	birth	weight.		
AGD	is	routinely	used	in	animal	toxicology	studies	and	is	sensitive	to	anti-androgenic	exposure.	In	
rodents	AGD	has	been	shown	to	reflect	the	amount	of	androgen	to	which	a	male	fetus	is	exposed	in	early	
development;	males	have	longer	AGD	than	females,	and	higher	in	utero	androgen	exposure	results	in	longer	
AGD.	Several	studies	have	found	that	exposure	to	chemicals	with	anti-androgenic	action	e.g.	phthalates	reduce	
AGD	in	male	infants	(Bornehag	et	al.,	2015;	T.	K.	Jensen	et	al.,	2016;	Swan	et	al.,	2015),	and	Huang	found	a	
negative	association	between	prenatal	phthalate	exposure	and	AGD	in	newborn	girls	(Huang,	Kuo,	Chou,	Lin,	&	
Lee,	2009).	To	our	knowledge,	no	other	studies	have	explored	a	potential	association	between	PFASs	and	AGD	
in	humans,	but	one	study	in	wild	mink	found	a	decreased	AGD	in	male	mink	exposed	to	PFASs	(Persson	&	
Magnusson,	2014),	a	finding	which	we	could	not	replicate.	They	did	not,	however,	study	female	minks.		
PFASs	may	have	endocrine	disrupting	properties	(Lau	et	al.,	2007).	Some	studies	have	suggested	that	
PFASs	antagonize	the	androgen	receptor	activity	(Du	et	al.,	2013);	the	effects	on	the	male	reproductive	system	
include	increased	germ	cell	apoptosis	(Feng	et	al.,	2009)	and	decreased	weight	of	the	reproductive	organs	(Shi	
et	al.,	2007).	In	addition,	PFASs	seem	to	affect	testosterone	concentrations	by	decreasing	the	expression	of	
genes	involved	in	steroid	biosynthesis	(Shi	et	al.,	2007;	Du	et	al.,	2013).	PFOA,	PFOS	and	PFDA	affect	both	
estradiol	and	testosterone	(Biegel,	Liu,	Hurtt,	&	Cook,	1995;	Bookstaff,	Moore,	Ingall,	&	Peterson,	1990;	A.	A.	
Jensen	&	Leffers,	2008;	Lau	et	al.,	2007;	Ye,	Su,	&	Ge,	2011).	The	effects	on	the	female	reproductive	system	
have	been	investigated	less	frequently,	but	one	study	suggested	that	estrous	cyclicity	may	be	disrupted	(Austin	
et	al.,	2003).	If	androgens	are	lowered	this	may	reduce	female	AGD.		
	
Our	study	has	several	strengths:	it	is	large	and	comprised	of	population-based	mother-child	pairs,	birth	
outcomes	were	well	reported,	and	AGDs	were	measured	three	times	by	trained	technicians.	However,	only	
42%	of	the	eligible	women	participated	in	this	study	and	participants	were	better	educated	than	non-
participants,	making	selection	bias	possible.	However,	the	pregnant	women	had	no	knowledge	of	their	PFASs	
exposure	or	the	birth	outcome	or	AGD	of	their	child	at	enrollment,	and	it	is	therefore	unlikely	that	PFASs	
exposure	was	associated	with	willingness	to	participate.	In	addition,	we	compared	women	across	a	range	of	
PFASs	exposures,	so	whether	they	represented	the	general	population	or	not	is	therefore	of	less	importance.	
We	adjusted	for	relevant	confounders,	but	we	cannot	exclude	the	possibility	of	residual	confounding	by	other	
factors	associated	with	PFASs	exposure	and	growth	measures,	such	as	e.g.	co-exposure	to	other	environmental	
chemicals,	lifestyle,	or	health	behavior.	We	performed	a	large	number	of	statistical	analyses	and	some	of	our	
results	may	therefore	be	chance	findings	due	to	multiple	testing.	However,	the	reduction	in	female	AGD	was	
seen	across	all	exposure	categories	and	in	all	five	PFAS	compounds.	
Shorter	AGD	has	been	associated	with	hypospadias	and	cryptorchidism	in	human	males	(Hsieh,	Breyer,	
Eisenberg,	&	Baskin,	2008;	Hsieh	et	al.,	2012;	Thankamony	et	al.,	2014),	as	well	as	reduced	serum-testosterone	
concentrations	and	reduced	semen	quality	(Eisenberg,	Hsieh,	Walters,	Krasnow,	&	Lipshultz,	2011;	Eisenberg,	
Jensen,	Walters,	Skakkebaek,	&	Lipshultz,	2012;	Mendiola,	Stahlhut,	Jorgensen,	Liu,	&	Swan,	2011).	AGD	in	
males	may	be	used	as	a	marker	of	testicular	dysgenesis	syndrome	(TDS),	which	suggests	that	the	increased	
incidence	of	reproductive	problems	such	as	hypospadias,	cryptorchidism,	testis	cancer	and	poor	semen	quality	
are	symptoms	of	a	shared	underlying	fetal	testicular	dysgenesis		resulting	from	a	disturbance	in	the	Sertoli	cell	
and	Leydig	cell	differentiation	during	fetal	life,	leading	to	impaired	testosterone	production	and	decreased	
virilization.	Less	is	known	about	AGD	in	females	and	their	reproductive	system	characteristics	(Mendiola	et	al.,	
2012).	However,	a	study	found	positive	associations	between	AGD	and	follicular	number	in	women	(Mendiola	
et	al.,	2012).	We	found	shorter	AGD	in	girls	prenatally	exposed	to	PFASs.	The	long	term	effects	of	reduced	AGD	
on	reproductive	health	in	girls	have	not	been	studied	but	need	to	be	addressed	in	future	studies.		
	5.	Conclusion	
In	conclusion,	we	found	that	maternal	PFASs	exposure	was	associated	with	reduced	AGD	in	girls,	although	no	
clear	association	was	seen	in	boys.	In	addition,	no	significant	association	between	maternal	PFASs	exposure	
and	birth	outcomes	were	observed,	however,	a	sex-dimorphism	pattern	was	suggested	with	a	tendency	
towards	lower	birth	weight	among	boys	and	higher	birth	weight	among	girls,	with	high	prenatal	PFOS,	PFNA	
and	PFDA	exposures	found.	Thus,	PFASs	may	have	endocrine	disrupting	abilities	as	suggested	by	changes	in	
AGD	and	a	sex-dimorphic	effect	on	birth	weight.	To	our	knowledge	this	study	is	the	first	to	report	a	possible	
association	between	PFASs	and	female	AGD,	and	no	clear	mechanisms	of	action	can	be	suggested.	Future	
studies	to	elucidate	this	are	urgently	needed.		
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